نتائج البحث - "Moor, Carl-Christian"

1

دورية أكاديمية

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

View this record from ISI Web of Science

2

Gibt es psychopathologische Besonderheiten bei Supersensitivitätspsychosen?

URL الوصول: https://www.europeana.eu/item/2048441/item_YH4GZ6GIR24HSSSKU66VPVNHAKBDLRIN?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCa

3

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

المؤلفون: Marson, Anthony, Burnside, Girvan, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin, Plumpton, Catrin, Hughes, Dyfrig A, Williamson, Paula, Baker, Gus A, Balabanova, Silviya, Taylor, Claire, Brown, Richard, Hindley, Dan, Howell, Stephen, Maguire, Melissa, Mohanraj, Rajiv, Smith, Philip E, Lanyon, Karen, Manford, Mark, Chitre, Manali, Parker, Alasdair, Swiderska, Nina, Pauling, James, Hughes, Adrian, Gupta, Rajat, Hanif, Sadia, Awadh, Mostafa, Ragunathan, Sharmini, Cable, Nicola, Cooper, Paul, Hindley, Daniel, Rakshi, Karl, Molloy, Sophie, Reuber, Markus, Ayonrinde, Kunle, Wilson, Martin, Saladi, Satyanarayana, Gibb, John, Funston, Lesley-Ann, Cassidy, Damhait, Boyd, Jonathan, Ratnayaka, Mal, Faza, Hani, Sadler, Martin, Al-Moasseb, Hassan, Galtrey, Clare, Wren, Damien, Olabi, Anas, Fuller, Geraint, Khan, Muhammed, Kallappa, Chetana, Chinthapalli, Ravi, Aji, Baba, Davies, Rhys, Foster, Kathryn, Hitiris, Nikolas, Hussain, Nahin, Dowson, Simon, Ellison, Julie, Sharrack, Basil, Gandhi, Vandna, Powell, Rob, Tittensor, Phil, Summers, Beatrice, Shashikiran, Sastry, Dison, Penelope J, Samarasekera, Shanika, McCorry, Doug, White, Kathleen, Nithi, Kannan, Richardson, Martin, Page, Rupert, Deekollu, David, Slaght, Sean, Warriner, Stephen, Ahmed, Mansoor, Chaudhuri, Abhijit, Chow, Gabriel, Artal, Javier, Kucinskiene, Danute, Sreenivasa, Harish, Velmurugan, Singara, Zipitis, Christos S, McLean, Brendan, Lal, Vaithianathar, Gregoriou, Angelous, Maddison, Paul, Pickersgill, Trevor, Anderson, Joseph, Lawthom, Charlotte, Whitlingum, Gabriel, Rakowicz, Wojtek, Kinton, Lucy, McLellan, Alisa, Vora, Nitish, Zuberi, Sameer, Kelso, Andrew, Hughes, Imelda, Martland, John, Emsley, Hedley, de Goede, Christian, Singh, RP, Moor, Carl-Christian, Aram, Julia, Sakthivel, Kumar, Nelapatla, Suresh, Rittey, Chris, Pinto, Ashwin, Cock, Hannah, Richardson, Anna, Houston, Erika, Cooper, Christopher, Lawson, Geoff, Massarano, Albert, Burness, Christine, Wieshmann, Udo, Dey, Indranil, Sivakumar, Puthuval, Yeung, Lap-Kong, Smith, Philip, Bentur, Hemalata, Heafield, Tom, Mathew, Anna, Smith, David, Jauhari, Praveen

المصدر: Mohanraj, R 2021, ' The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. ', Lancet (London, England) . https://doi.org/10.1016/s0140-6736(21)00246-4
Lancet (London, England)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b273551036e936467f978b4cb9f9f3
https://eprints.gla.ac.uk/238444/1/238444.pdf

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

4

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

المؤلفون: Marson, Anthony, Burnside, Girvan, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin, Plumpton, Catrin, Hughes, Dyfrig A., Williamson, Paula, Baker, Gus A., Balabanova, Silviya, Taylor, Claire, Brown, Richard, Hindley, Dan, Howell, Stephen, Maguire, Melissa, Mohanraj, Rajiv, Smith, Philip E., Lanyon, Karen, Manford, Mark, Chitre, Manali, Parker, Alasdair, Swiderska, Nina, Pauling, James, Hughes, Adrian, Gupta, Rajat, Hanif, Sadia, Awadh, Mostafa, Ragunathan, Sharmini, Cable, Nicola, Cooper, Paul, Hindley, Daniel, Rakshi, Karl, Molloy, Sophie, Reuber, Markus, Ayonrinde, Kunle, Wilson, Martin, Saladi, Satyanarayana, Gibb, John, Funston, Lesley-Ann, Cassidy, Damhait, Boyd, Jonathan, Ratnayaka, Mal, Faza, Hani, Sadler, Martin, Al-Moasseb, Hassan, Galtrey, Clare, Wren, Damien, Olabi, Anas, Fuller, Geraint, Khan, Muhammed, Kallappa, Chetana, Chinthapalli, Ravi, Aji, Baba, Davies, Rhys, Foster, Kathryn, Hitiris, Nikolas, Hussain, Nahin, Dowson, Simon, Ellison, Julie, Sharrack, Basil, Gandhi, Vandna, Powell, Rob, Tittensor, Phil, Summers, Beatrice, Shashikiran, Sastry, Dison, Penelope J, Samarasekera, Shanika, McCorry, Doug, White, Kathleen, Nithi, Kannan, Richardson, Martin, Page, Rupert, Deekollu, David, Slaght, Sean, Warriner, Stephen, Ahmed, Mansoor, Chaudhuri, Abhijit, Chow, Gabriel, Artal, Javier, Kucinskiene, Danute, Sreenivasa, Harish, Velmurugan, Singara, Zipitis, Christos S., McLean, Brendan, Lal, Vaithianathar, Gregoriou, Angelous, Maddison, Paul, Pickersgill, Trevor, Anderson, Joseph, Lawthom, Charlotte, Whitlingum, Gabriel, Rakowicz, Wojtek, Kinton, Lucy, McLellan, Alisa, Vora, Nitish, Zuberi, Sameer, Kelso, Andrew, Hughes, Imelda, Martland, John, Emsley, Hedley, de Goede, Christian, Singh, RP, Moor, Carl-Christian, Aram, Julia, Sakthivel, Kumar, Nelapatla, Suresh, Rittey, Chris, Pinto, Ashwin, Cock, Hannah, Richardson, Anna, Houston, Erika, Cooper, Christopher, Lawson, Geoff, Massarano, Albert, Burness, Christine, Wieshmann, Udo, Dey, Indranil, Sivakumar, Puthuval, Yeung, Lap-Kong, Smith, Philip, Bentur, Hemalata, Heafield, Tom, Mathew, Anna, Smith, David, Jauhari, Praveen

المصدر: Mohanraj, R 2021, ' The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. ', Lancet (London, England) . https://doi.org/10.1016/s0140-6736(21)00247-6
Lancet (London, England)